These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 16390928)

  • 1. Unlabeled uses of botulinum toxins: a review, part 1.
    Cheng CM; Chen JS; Patel RP
    Am J Health Syst Pharm; 2006 Jan; 63(2):145-52. PubMed ID: 16390928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unlabeled uses of botulinum toxins: a review, part 2.
    Cheng CM; Chen JS; Patel RP
    Am J Health Syst Pharm; 2006 Feb; 63(3):225-32. PubMed ID: 16434781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of the FDA-approved uses of botulinum toxins, including data suggesting efficacy in pain reduction.
    Lew MF
    Clin J Pain; 2002; 18(6 Suppl):S142-6. PubMed ID: 12569961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin for glabellar lines: a review of the efficacy and safety of currently available products.
    Dessy LA; Fallico N; Mazzocchi M; Scuderi N
    Am J Clin Dermatol; 2011 Dec; 12(6):377-88. PubMed ID: 21877763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New botulinum toxin approved with REMS.
    Thompson CA
    Am J Health Syst Pharm; 2010 Sep; 67(18):1486. PubMed ID: 20811019
    [No Abstract]   [Full Text] [Related]  

  • 6. Application of botulinum toxin to clinical therapy: advances and cautions.
    Levy NS; Lowenthal DT
    Am J Ther; 2012 Jul; 19(4):281-6. PubMed ID: 22481607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin in the management of head and neck disorders.
    Nagi R; Patil DJ; Sahu S; Jain S; Naidu GS
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Apr; 123(4):419-428. PubMed ID: 28159584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology and clinical applications of botulinum toxins A and B.
    Thakker MM; Rubin PA
    Int Ophthalmol Clin; 2004; 44(3):147-63. PubMed ID: 15211183
    [No Abstract]   [Full Text] [Related]  

  • 9. Botulinum toxin B: a review of its therapeutic potential in the management of cervical dystonia.
    Figgitt DP; Noble S
    Drugs; 2002; 62(4):705-22. PubMed ID: 11893235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum neurotoxin serotype A: a clinical update on non-cosmetic uses.
    Charles PD
    Am J Health Syst Pharm; 2004 Nov; 61(22 Suppl 6):S11-23. PubMed ID: 15598005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDA Approvals and Consensus Guidelines for Botulinum Toxins in the Treatment of Dystonia.
    Spiegel LL; Ostrem JL; Bledsoe IO
    Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32429600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanding use of botulinum toxin.
    Bhidayasiri R; Truong DD
    J Neurol Sci; 2005 Aug; 235(1-2):1-9. PubMed ID: 15990116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations.
    Bhidayasiri R; Cardoso F; Truong DD
    Eur J Neurol; 2006 Feb; 13 Suppl 1():21-9. PubMed ID: 16417594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefits and Risks of Non-Approved Injection Regimens for Botulinum Toxins in Spasticity.
    Santamato A; Panza F
    Drugs; 2017 Sep; 77(13):1413-1422. PubMed ID: 28726023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of botulinum toxins to treat hyperhidrosis and gustatory sweating syndrome.
    Glaser DA
    Neurotox Res; 2006 Apr; 9(2-3):173-7. PubMed ID: 16785115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of botulinum toxin type-B in the treatment of patients who have become unresponsive to botulinum toxin type-A -- initial experiences.
    Barnes MP; Best D; Kidd L; Roberts B; Stark S; Weeks P; Whitaker J
    Eur J Neurol; 2005 Dec; 12(12):947-55. PubMed ID: 16324088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin treatment of adult spasticity : a benefit-risk assessment.
    Sheean G
    Drug Saf; 2006; 29(1):31-48. PubMed ID: 16454533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of botulinum neurotoxin preparations for the treatment of cervical dystonia.
    Chapman MA; Barron R; Tanis DC; Gill CE; Charles PD
    Clin Ther; 2007 Jul; 29(7):1325-37. PubMed ID: 17825685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Indications and management of botulinum toxin].
    Singer C
    Rev Neurol; 1999 Jul 16-31; 29(2):157-62. PubMed ID: 10528331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of botulinum neurotoxins.
    Lowe NJ
    J Cosmet Laser Ther; 2007; 9 Suppl 1():11-6. PubMed ID: 17885881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.